Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman.

Slides:

Advertisements

Similar presentations

Heart Transplant vs Left Ventricular Assist Device in Heart Transplant-Eligible Patients Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C.

Advertisements

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Survival After Single Versus Bilateral Lung Transplantation for High-Risk Patients With Pulmonary Fibrosis Eric S. Weiss, MD, MPH, Jeremiah G. Allen,

High Risk of Prosthetic Valve Endocarditis and Death After Valve Replacement Operations in Dialysis Patients Danielle K. Farrington, MD, Patrick D. Kilgo,

Survival Benefit of Aortic Valve Replacement in Patients With Severe Aortic Stenosis With Low Ejection Fraction And Low Gradient With Normal Ejection.

What Predicts Long-Term Survival After Heart Transplantation

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y

Survival on the Heart Transplant Waiting List: Impact of Continuous Flow Left Ventricular Assist Device as Bridge to Transplant Jaimin R. Trivedi, MD,

Laura Harvey, MD, Christopher Holley, MD, Samit S

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD

The effect of center volume on the incidence of postoperative complications and their impact on survival after lung transplantation Arman Kilic, MD,

Video-Assisted Thoracoscopic Left Ventricular Pacing in Patients With and Without Previous Sternotomy Katharine E. Nelson, MBBS, MRCP, Matthew G.D. Bates,

Heart Transplantation for the Failing Fontan

Dhaval Chauhan, MD, Alexis K

Michael E. Halkos, MD, Patrick Kilgo, MS, Omar M

Continuous Flow Left Ventricular Assist Device Outcomes in Commercial Use Compared With the Prior Clinical Trial Ranjit John, MD, Yoshifumi Naka, MD,

ABO-Identical Blood Group Matching Has No Survival Benefit for AB Heart Transplant Recipients Henrik Bergenfeldt, MD, Peter Höglund, MD, PhD, Bodil Andersson,

Operative Results and Outcomes in Children With Shone's Anomaly

Michael Eberlein, MD, PhD, Robert M

Surgical Ventricular Restoration for Advanced Congestive Heart Failure: Should Pulmonary Hypertension Be a Contraindication? Nishant D. Patel, BA, Jason.

The Survival Benefit of Simultaneous Heart-Kidney Transplantation Extends Beyond Dialysis-Dependent Patients Arman Kilic, MD, Joshua C. Grimm, MD, Glenn.

Age-Related Outcomes of the Ross Procedure Over 20 Years

Varun Puri, MD, Andrew Tran, MS, Jennifer M. Bell, BS, Traves D

Pulmonary Resection in the Treatment of Multidrug-Resistant Tuberculosis: A Retrospective Study of 56 Cases Haifeng Wang, MM, Hongsheng Lin, MM, Gening.

Darrell Wu, MD, Matt D. Price, MS, Hiruni S. Amarasekara, MS, Susan Y

Fenton H. McCarthy, MD, Dale Kobrin, BA, J. Eduardo Rame, MD, Peter W

Outcomes in Patients Bridged With Univentricular and Biventricular Devices in the Modern Era of Heart Transplantation Joshua C. Grimm, MD, Christopher.

Matthew L. Williams, MD, Jaimin R. Trivedi, MD, MPH, Kelly C

Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation Ann C.

Allen Cheng, MD, Erin M. Schumer, MD, MPH, Jaimin R

Elliot Wakeam, MD, MPH, James P. Byrne, MD, Gail E

Jaimin R. Trivedi, MD, MPH, Allen Cheng, MD, Michele Gallo, MD, Erin M

Outcomes on Continuous Flow Left Ventricular Assist Devices: A Single Institutional 9- Year Experience Jeffrey A. Morgan, MD, Pauline H. Go, MD, Linnea.

Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant George J. Arnaoutakis, MD, Timothy J.

Michiaki Imamura, MD, PhD, Amy M

Acute Kidney Injury Increases Mortality After Lung Transplantation

Eric S. Weiss, MD, MPH, Jeremiah G. Allen, MD, Christian A

Colonization With Multiresistant Bacteria: Impact on Ventricular Assist Device Patients Maria Papathanasiou, MD, Julia Pohl, MD, Rolf Alexander Jánosi,

Arman Kilic, MD, Eric S. Weiss, MD, MPH, Jeremiah G

Kara A. Haggerty, BA, Timothy J. George, MD, George J

Right Heart Dysfunction After Left Ventricular Assist Device Implantation: A Comparison of the Pulsatile HeartMate I and Axial-Flow HeartMate II Devices

Posttransplant Outcomes Among Septuagenarians Bridged to Transplantation With Continuous-Flow Left Ventricular Assist Devices Shinichi Fukuhara, MD,

Mechanical Circulatory Support Pathways That Maximize Post-Heart Transplant Survival Tara Karamlou, MD, MS, Jill Gelow, MD, Brian S. Diggs, PhD, Frederick.

Dhaval Chauhan, MD, Alexis K

William M. Whited, MD, Paul Henley, BS, Erin M

Pretransplant Panel Reactive Antibodies in Human Lung Transplantation: An Analysis of Over 10,000 Patients Ashish S. Shah, MD, Lois Nwakanma, MD, Christopher.

Mechanical Circulatory Support and Heart Transplantation: Donor and Recipient Factors Influencing Graft Survival Simon Maltais, MD, PhD, Nikhil P. Jaik,

Early Outcomes With Marginal Donor Hearts Compared With Left Ventricular Assist Device Support in Patients With Advanced Heart Failure Erin M. Schumer,

Attila Dubecz, MD, Thomas J. Watson, MD, Daniel P

Correction of Tetralogy of Fallot and of Pulmonary Atresia with Ventricular Septal Defect in Adults Jürgen Hörer, MD, Julia Friebe, MD, Christian Schreiber,

Survival After Isolated Coronary Artery Bypass Grafting in Patients With Severe Left Ventricular Dysfunction Waleed A. Ahmed, MD, Phillip J. Tully, BHSc(Hons),

Bleeding Complications and Blood Product Utilization With Left Ventricular Assist Device Implantation Justin M. Schaffer, MS, George J. Arnaoutakis,

Is There a Benefit to Prolonging the Interval Between Neoadjuvant Chemoradiation and Esophagectomy in Esophageal Cancer? Anna Lee, MD, MPH, Andrew T.

Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant.

Trends in Patient Characteristics and Outcomes of Coronary Artery Bypass Grafting in the 2000 to 2012 Medicare Population Christian McNeely, MD, Stephen.

Invited Commentary The Annals of Thoracic Surgery

Preoperative Performance Status Impacts Perioperative Morbidity and Mortality After Lung Transplantation Joshua C. Grimm, MD, Vicente Valero, MD, Arman.

The Impact of Volume Reduction on Early and Long-Term Outcomes in Surgical Ventricular Restoration for Severe Heart Failure Nathan Wm. Skelley, BS, Jeremiah.

Increased Mortality at Low-Volume Orthotopic Heart Transplantation Centers: Should Current Standards Change? Eric S. Weiss, MD, Robert A. Meguid, MD,

Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices Forum Kamdar, MD, Ranjit John,

Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy Ranjit.

Farhan Zafar, MD, John L. Jefferies, MD, MPH, Christine J

Late Aortic Insufficiency Related to Poor Prognosis During Left Ventricular Assist Device Support Koichi Toda, MD, PhD, Tomoyuki Fujita, MD, Keitaro.

Creation of a Quantitative Score to Predict the Need for Mechanical Support in Children Awaiting Heart Transplant Ryan R. Davies, MD, Shylah Haldeman,

Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow Era Veli K. Topkara, MD, Sreekanth.

Ventricular Assist Device Implant in the Elderly Is Associated With Increased, but Respectable Risk: A Multi-Institutional Study Pavan Atluri, MD, Andrew.

Jonathan P. Martin, BA, Jeremiah G. Allen, MD, Eric S

Marginal Donor Use in Patients Undergoing Heart Transplantation With Left Ventricular Assist Device Explantation Marat Fudim, MD, Mary E. Davis, MS,

Heart Transplant Program Volume Is Not a Measure of Quality

Significance of Postoperative Acute Renal Failure After Continuous-Flow Left Ventricular Assist Device Implantation Jamil Borgi, MD, Athanasios Tsiouris,

Presentation transcript:

Should Patients 60 Years and Older Undergo Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices? Jeremiah G. Allen, MD, Arman Kilic, MD, Eric S. Weiss, MD, MPH, George J. Arnaoutakis, MD, Timothy J. George, MD, Ashish S. Shah, MD, John V. Conte, MD The Annals of Thoracic Surgery Volume 94, Issue 6, Pages 2017-2024 (December 2012) DOI: 10.1016/j.athoracsur.2012.06.009 Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 1 Number of heart transplantations performed during the study period in patients 60 years of age or older, stratified by bridge-to-transplantation modality (percentages of orthotopic heart transplantations [OHTs] in this population by modality also shown) (UNOS data, December 2010). (LVAD = left ventricular assist devices.) The Annals of Thoracic Surgery 2012 94, 2017-2024DOI: (10.1016/j.athoracsur.2012.06.009) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 2 Kaplan-Meier estimates of survival for heart transplant recipients 60 years of age or older, stratified by bridge-to-transplantation modality (UNOS data, December 2010). (LVAD = left ventricular assist device.) The Annals of Thoracic Surgery 2012 94, 2017-2024DOI: (10.1016/j.athoracsur.2012.06.009) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions

Fig 3 Conditional Kaplan-Meier estimates of survival, censoring for deaths in the first 30 days after transplantation for heart transplant recipients 60 years of age or older stratified by bridge-to-transplantation modality (UNOS data, December 2010). (LVAD = left ventricular assist device.) The Annals of Thoracic Surgery 2012 94, 2017-2024DOI: (10.1016/j.athoracsur.2012.06.009) Copyright © 2012 The Society of Thoracic Surgeons Terms and Conditions